Where Is the Limit of Prostate Cancer Biomarker Research? Systematic Investigation of Potential Prognostic and Diagnostic Biomarkers

BMC Urology - United Kingdom
doi 10.1186/s12894-019-0479-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Diagnostic and Prognostic Biomarker Potential of Kallikrein Family Genes in Different Cancer Types

Oncotarget
Oncology
2018English

LncRNA as a Diagnostic and Prognostic Biomarker in Bladder Cancer: A Systematic Review and Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2018English

Upregulation of WEE1 Is a Potential Prognostic Biomarker for Patients With Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Increased KIF4A Expression Is a Potential Prognostic Factor in Prostate Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Use of Classical and Novel Biomarkers as Prognostic Risk Factors for Localised Prostate Cancer: A Systematic Review

Health Technology Assessment
MedicineHealth Policy
2009English

ERRATUM: Acknowledgments Correction. Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer

Genomics and Informatics
EvolutionEcologyGeneticsSystematicsHealth InformaticsBehavior
2015English

O1-19-2Histone Demethylase KDM4C Is a Novel Oncogene and Prognostic Biomarker for Prostate Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

TRPM8 in Prostate Cancer Cells: A Potential Diagnostic and Prognostic Marker With a Secretory Function?

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2006English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy